Advanced search
Publication Cover
Platelets Volume 14, 2003 - Issue 7-8
Submit an article Journal homepage
47
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia

Enver Atalar Hacettepe University Medical Faculty, Department of Cardiology, Ankara, TurkeyCorrespondence[email protected]
,
Ibrahim C. Haznedaroglu Hacettepe University Medical Faculty, Department of Hematology, Ankara, Turkey
,
Tayfun Acil Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Necla Ozer Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Harun Kilic Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Kenan Ovunc Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Serdar Aksoyek Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Nasi˙h Nazli˙ Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Sirri Kes Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Giray Kabakçi˙ Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
,
Serafettin Kirazli˙ Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
&
Ferhan Ozmen Hacettepe University Medical Faculty, Department of Cardiology, Ankara, Turkey
 show all
Pages 407-411 | Published online: 07 Jul 2009

References

  • Wolf P A, Abbot R D, Kannel W B. Atrial fibrillation: as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983–88.
  • Feng D, D’Agostino B R, Silberschatz H, Lipinska I, Massaro J, Levy D, et al. Hemostatic state and atrial fibrillation (The Framingham Offspring Study). Am J Cardiol 2001; 87: 168–171.
  • Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn Circ J 1981; 22: 143–9.
  • Petersen P, Godtfredsen J. Embolic complication in parox-ysmal atrial fibrillation. Stroke 1986; 17: 622–6.
  • Yamaguchi K, Furui H, Taniguchi N, Sotobata I. Plasma b-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 1986; 27: 481–7.
  • Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the risk of stroke in non-valvular atrial fibrillation. Stroke 1990; 21: 47–51.
  • Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hori N. Increased intra-cardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990; 16: 377–80.
  • Sohara H, Miyahara K. Effect of atrial fibrillation on the fibrinocoagulation system: in patients with paroxysmal atrial fibrillation. Jpn Circ J 1994; 58: 821–26.
  • Lip G Y H, Lip P L, Zarifis J, Watson R D, Bareford D, Lowe G D, Beevers D G. Fibrin D-dimer and b-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Circulation 1996; 94: 425–31.
  • Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997; 29: 106–12.
  • Roldan V, Marin F, Marco P, Martinez J G, Calatayud C, Sogorb F. Hypofibrinolysis in atrial fibrillation. Am Heart J 1998; 136: 956–60.
  • Li-Saw-Hee F L, Blann A D, Lip G Y H. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Eur Heart J 2001; 22: 1741–47.
  • Atalar E, Ozmen F, Haznedaroglu I, Ozer N, Aksoyek S, Ovunc K, et al. Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheu-matic atraial fibrillation. Int J Hematology 2002; 76: 192–95.
  • Sopher S M, Camm A J. Atrial fibrillation – maintenance of sinus rhythm versus rate control. Am J Cardiol 1996; 77: 24A–38A.
  • Lip G Y H, Rumley A, Dunn F G. Plasma fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence of intermediate levels of intravascular thrombogenesis. Am Heart J 1996; 131: 724–30.
  • Lip G Y H. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? Lancet 1977; 349: 1565–66.
  • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized trials. Arch Intern Med 1994; 154: 1449–57.
  • Atluru V L, Epstein L G, Gootman N. Childhood stroke and supraventricular tachycardia. Pediatr Neurol 1985; 1: 54–6.
  • Aronow W S, Ahn C, Mercando A D, Epstein S, Gutstein H. Correlation of paroxysmal supraventricular tachycardia, atrial fibrillation, and sinus rhythm with incidences of new thromboembolic stroke in 1476 old-old patients. Aging 1996; 8: 32–4.
  • Baumgartner H R. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973; 5: 167–79.
  • Turitto V T, Weiss H J. Red blood cells: their role in thrombosis formation. Science 1980; 207: 541–43.
  • Shapiro E P, Effron M B, Lima S, Ouyang P, Siu CO, Bush D. Transient atrial dysfunction after cardioversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 1988; 62: 1202–07.
  • Nishino M, Hoshida S, Tanouchi J, Ito T, Kato J, Iwai K, et al. Time to recover from atrial hormonal, mechanical, and electrical dysfunction after successful electrical cardioversion of persistent atrial fibrillation. Am J Cardiol 2000; 85: 1451–54.
  • Wozakosa-Kaplon B, Opolski G. Concominant recovery of atrial mechanical and endocrine function after cardioversion in patients with persistent atrial fibrillation. J Am Coll Cardiol 2003; 41: 1716–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.